333 related articles for article (PubMed ID: 27601155)
1. Effect of Gonadotropin and Adrenocorticotropic Hormone Secretion on Invasiveness of Clinically Nonfunctioning Pituitary Adenomas: A Cell Culture Study.
Usui S; Hama S; Tominaga A; Kinoshita Y; Kurisu K
World Neurosurg; 2016 Dec; 96():578-584.e1. PubMed ID: 27601155
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
3. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
4. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas.
Sanno N; Teramoto A; Sugiyama M; Itoh Y; Osamura RY
Am J Clin Pathol; 1996 Jul; 106(1):16-21. PubMed ID: 8701926
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
[TBL] [Abstract][Full Text] [Related]
6. Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay.
Yamada S; Asa SL; Kovacs K; Muller P; Smyth HS
J Clin Endocrinol Metab; 1989 Jan; 68(1):73-80. PubMed ID: 2535851
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
[TBL] [Abstract][Full Text] [Related]
8. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
[TBL] [Abstract][Full Text] [Related]
9. Plurihormonal pituitary adenomas.
Scheithauer BW; Horvath E; Kovacs K; Laws ER; Randall RV; Ryan N
Semin Diagn Pathol; 1986 Feb; 3(1):69-82. PubMed ID: 3039632
[TBL] [Abstract][Full Text] [Related]
10. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
11. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
12. 'Silent' somatotropinoma.
Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
[TBL] [Abstract][Full Text] [Related]
13. Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas.
Lania A; Gangi E; Romoli R; Losa M; Travaglini P; Meringolo D; Ambrosi B; Faglia G; Beck-Peccoz P; Spada A
Eur J Clin Invest; 2002 May; 32(5):335-40. PubMed ID: 12027873
[TBL] [Abstract][Full Text] [Related]
14. Pathology of invasive pituitary tumors with special reference to functional classification.
Scheithauer BW; Kovacs KT; Laws ER; Randall RV
J Neurosurg; 1986 Dec; 65(6):733-44. PubMed ID: 3095506
[TBL] [Abstract][Full Text] [Related]
15. TRH is a tonic secretagogue in growth hormone secreting but not in nonfunctioning pituitary tumors.
Somjen D; Tordjman K; Greenman Y; Kohen F; Ouaknine GE; Stern N
J Endocrinol Invest; 1999 Feb; 22(2):104-8. PubMed ID: 10195376
[TBL] [Abstract][Full Text] [Related]
16. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
Kwekkeboom DJ; de Jong FH; Lamberts SW
J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
Umeoka K; Sanno N; Oyama K; Tahara S; Kurotani R; Ikuyama S; Nakashima M; Watanabe T; Osamura RY; Teramoto A
Mod Pathol; 2001 Dec; 14(12):1232-6. PubMed ID: 11743045
[TBL] [Abstract][Full Text] [Related]
19. Characteristic location and growth patterns of functioning pituitary adenomas: correlation with histological distribution of hormone-secreting cells in the pituitary gland.
Baik JS; Lee MH; Ahn KJ; Choi HS; Jung SL; Kim BS; Jeun SS; Hong YK
Clin Imaging; 2015; 39(5):770-4. PubMed ID: 26115915
[TBL] [Abstract][Full Text] [Related]
20. Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas.
Katznelson L; Alexander JM; Bikkal HA; Jameson JL; Hsu DW; Klibanski A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1343-51. PubMed ID: 1375599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
